Recent trends in endoscopic bariatric therapies

Clinical Endoscopy

Volumn 50, Issue 1, 2017, Pages 11-16

  Choi, Hyuk Soon ^a   Chun, Hoon Jai ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Bariatrics; Endoscopy; Gastroplasty; Obesity

Indexed keywords

EID: 85011673152     PISSN: 22342400     EISSN: 22342443     Source Type: Journal    
DOI: 10.5946/ce.2017.007     Document Type: Review

References (45)

1. ASGE Bariatric Endoscopy Task Force; ASGE Technology Committee, Abu Dayyeh BK, et al. Endoscopic bariatric therapies. Gastrointest Endosc 2015;81:1073-1086.
2. Espinet-Coll E, Nebreda-Durán J, Gómez-Valero JA, et al. Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig 2012;104:72-87.
3. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet 2016;387:1377-1396.
4. Lee CM, Colagiuri S, Ezzati M, Woodward M. The burden of cardiovascular disease associated with high body mass index in the Asia-Pacific region. Obes Rev 2011;12:e454-e459.
5. Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-1096.
6. Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes Metab Syndr Obes 2010;3:285-295.
7. Gotthardt JD, Bello NT. Can we win the war on obesity with pharmaco-therapy? Expert Rev of Clin Pharmacol 2016;9:1289-1297.
8. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med 2014;370:2002-2013.
9. ASGE Technology Committee, Kethu SR, Banerjee S, et al. Endoluminal bariatric techniques. Gastrointest Endosc 2012;76:1-7.
10. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg 2014;149:275-287.
11. Stimac D, Majanović SK. Endoscopic approaches to obesity. Dig Dis 2012;30:187-195.
12. Alfredo G, Roberta M, Massimiliano C, Michele L, Nicola B, Adriano R. Long-term multiple intragastric balloon treatment-a new strategy to treat morbid obese patients refusing surgery: prospective 6-year follow-up study. Surg Obes Relat Dis 2014;10:307-311.
13. Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics® intragastric balloon (BIB®). Single ambulatory center Spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg 2011;21:5-9.
14. Mion F, Ibrahim M, Marjoux S, et al. Swallowable Obalon® gastric balloons as an aid for weight loss: a pilot feasibility study. Obes Surg 2013;23:730-733.
15. Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg 2011;21:1499-1507.
16. Trande P, Mussetto A, Mirante VG, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg 2010;20:1227-1230.
17. Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity. J Clin Gastroenterol 2008;42:48-53.
18. Carvalho GL, Barros CB, Moraes CE, et al. The use of an improved intragastric balloon technique to reduce weight in pre-obese patients-preliminary results. Obes Surg 2011;21:924-927.
19. Gaggiotti G, Tack J, Garrido AB Jr, Palau M, Cappelluti G, Di Matteo F. Adjustable totally Implantable intragastric prosthesis (ATIIP) - Endog-ast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey. Obes Surg 2007;17:949-956.
20. Gaur S, Levy S, Mathus-Vliegen L, Chuttani R. Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc 2015;81:1330-1336.
21. ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh BK, et al. ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015;82:425-438.e5.
22. Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT. Current status of intragastric balloon for obesity treatment. World J Gastroenterol 2016;22:5495-5504.
23. ASGE Technology Committee, Banerjee S, Barth BA, et al. Endoscopic closure devices. Gastrointest Endosc 2012;76:244-251.
24. Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc 2013;78:530-535.
25. Song Y, Choi HS, Kim K, et al. A simple novel endoscopic successive suture device: a validation study for closure strength and reproducibility. Endoscopy 2013;45:655-660.
26. Mori H, Kobara H, Fujihara S, et al. Feasibility of pure EFTR using an innovative new endoscopic suturing device: the double-arm-bar suturing system (with video). Surg Endosc 2014;28:683-690.
27. Kim Y, Choi HS, Kim K, et al. A novel endoscopic surgical device for gastric volume reduction bariatric surgery. International Journal of Precision Engineering and Manufacturing 2016;17:467-472.
28. López-Nava G, Bautista-Castaño I, Jimenez A, de Grado T, Fernandez-Corbelle JP. The primary obesity surgery endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis 2015;11:861-865.
29. Lopez-Nava G, Galvão MP, Bautista-Castaño I, Jimenez-Baños A, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty: how I do it? Obes Surg 2015;25:1534-1538.
30. Sharaiha RZ, Kedia P, Kumta N, et al. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy 2015;47:164-166.
31. Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK. Effect of the EndoBarrier gastrointestinal liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies. BMJ Open 2013;3:e003417.
32. Rodriguez L, Rodriguez P, Gómez B, et al. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease. Endoscopy 2013;45:595-604.
33. Rohde U, Hedbäck N, Gluud LL, Vilsbøll T, Knop FK. Effect of the EndoBarrier gastrointestinal liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 2016;18:300-305.
34. Sandler BJ, Rumbaut R, Swain CP, et al. One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity. Surg Endosc 2015;29:3298-3303.
35. Sauer N, Rösch T, Pezold J, et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels. Obes Surg 2013;23:1727-1733.
36. Rajagopalan H, Cherrington AD, Thompson CC, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care 2016;39:2254-2261.
37. Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology 2013;145:1245-1252.e1-e5.
38. Forssell H, Norén E. A novel endoscopic weight loss therapy using gastric aspiration: results after 6 months. Endoscopy 2015;47:68-71.
39. Horbach T, Meyer G, Morales-Conde S, et al. Closed-loop gastric electrical stimulation versus laparoscopic adjustable gastric band for the treatment of obesity: a randomized 12-month multicenter study. Int J Obes (Lond) 2016;40:1891-1898.
40. Verdam FJ, Schouten R, Greve JW, Koek GH, Bouvy ND. An update on less invasive and endoscopic techniques mimicking the effect of bariatric surgery. J Obes 2012;2012:597871.
41. Lebovitz HE, Ludvik B, Yaniv I, et al. Treatment of patients with obese type 2 diabetes with tantalus-DIAMOND® gastric electrical stimulation: normal triglycerides predict durable effects for at least 3 Years. Horm Metab Res 2015;47:456-462.
42. Chiu JD, Soffer E. Gastric electrical stimulation for obesity. Curr Gastroenterol Rep 2015;17:424.
43. Abell TL, Johnson WD, Kedar A, et al. A double-masked, randomized, placebo-controlled trial of temporary endoscopic mucosal gastric electrical stimulation for gastroparesis. Gastrointest Endosc 2011;74:496-503.e3.
44. Ayinala S, Batista O, Goyal A, et al. Temporary gastric electrical stimulation with orally or PEG-placed electrodes in patients with drug refractory gastroparesis. Gastrointest Endosc 2005;61:455-461.
45. Lonys L, Vanhoestenberghe A, Huberty V, et al. Design and implementation of a less invasive gastrostimulator. Eur J Transl Myol 2016;26:6019.